The infectious etiology of vasculitis

References

• Jennette JC, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187–192
   PubMed Web of Science ®Google Scholar
• Rodriguez-Pla A, Stone JH. Vasculitis and systemic infections. Curr Opin Rheumatol 2006; 18: 39–47
   PubMedGoogle Scholar
• Cohen-Teravet JW, Stegeman CA. Infections and vaculitis. Infections and autoimmunity, Y Shoenfeld, NY Rose. Elsevier, Amsterdam/San Diego 2004; 549–557
   Google Scholar
• Misiani R. Virus-associated vasculitides: Pathogenesis. Inflammatory diseases of blood vessels, GS Hoffman, CM Weyand. Marcel Dekker, New York 2002; 553–564
   Google Scholar
• Bechah Y, et al. Infection of endothelial cells with virulent Rickettsia prowazekii increases the transmigration of leukocytes. J Infect Dis 2008; 197: 142–147
   PubMed Web of Science ®Google Scholar
• Matussek A, et al. Infection of human endothelial cells with Staphylococcus aureus induces transcription of genes encoding an innate immunity response. Scand J Immunol 2005; 61: 536–544
   PubMedGoogle Scholar
• Beekhuizen H, et al. Infection of human vascular endothelial cells with Staphylococcus aureus induces hyperadhesiveness for human monocytes and granulocytes. J Immunol 1997; 158: 774–782
   PubMed Web of Science ®Google Scholar
• Ferri C, Zignego A. Relation between infection and autoimmunity in mixed cryoglobulinemia. Curr Opin Rheumatol 2000; 12: 53–60
   PubMedGoogle Scholar
• Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490–1495
   PubMed Web of Science ®Google Scholar
• Strassburg CP, Vogel A, Manns MP. Autoimmunity and hepatitis C. Autoimmun Rev 2003; 2: 322–331
   PubMed Web of Science ®Google Scholar
• Theofilopoulos AN, Dixon FJ. Immune complexes in human diseases: A review. Am J Pathol 1980; 100: 529–594
   PubMedGoogle Scholar
• Stokol T, et al. C1q governs deposition of circulating immune complexes and leukocyte Fcgamma receptors mediate subsequent neutrophil recruitment. J Exp Med 2004; 200: 835–846
   PubMed Web of Science ®Google Scholar
• Feng X, et al. Cooperation of C1q receptors and integrins in C1q-mediated endothelial cell adhesion and spreading. J Immunol 2002; 168: 2441–2448
   PubMedGoogle Scholar
• Racanelli V, et al. Molecular characterization of B cell clonal expansions in the liver of chronically hepatitis C virus-infected patients. J Immunol 2001; 167: 21–29
   PubMed Web of Science ®Google Scholar
• Cheema GS, et al. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum 2001; 44: 1313–1319
   PubMed Web of Science ®Google Scholar
• Sene D, et al. Hepatitis C virus-associated B-cell proliferation—the role of serum B lymphocyte stimulator (BLyS/BAFF). Rheumatology (Oxford) 2007; 46: 65–69
   PubMedGoogle Scholar
• De Vita S, Quartuccio L, Fabris M. Hepatitis C virus infection, mixed crioglobulinemia cryoglobulinemia and BLyS upregulation: Targeting the infectious trigger, the autoimmune response, or both?. Autoimmun Rev, in press
   Google Scholar
• Baker KP. BLyS—an essential survival factor for B cells: Basic biology, links to pathology and therapeutic target. Autoimmun Rev 2004; 3: 368–375
   PubMed Web of Science ®Google Scholar
• Ram M, Gershwin ME, Shoenfeld Y. Hepatitis B Virus (HBV) and autoimmune disease. Clin Rev Allergy Immunol 2008; 34: 85–102
   PubMedGoogle Scholar
• Duffy J, et al. Polyarthritis, polyarteritis and hepatitis B. Medicine (Baltimore) 1976; 55: 19–37
   PubMed Web of Science ®Google Scholar
• Gower RG, et al. Small vessel vasculitis caused by hepatitis B virus immune complexes. Small vessel vasculitis and HBsAG. J Allergy Clin Immunol 1978; 62: 222–228
   PubMed Web of Science ®Google Scholar
• Naides SJ. Known causes of vasculitis in man. Cleve Clin J Med 2002; 2(69 Suppl)SII15–SII19
   Google Scholar
• Guillevin L, et al. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine (Baltimore) 1995; 74: 238–253
   PubMed Web of Science ®Google Scholar
• Guillevin L, et al. Hepatitis B virus-associated polyarteritis nodosa: Clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore) 2005; 84: 313–322
   PubMed Web of Science ®Google Scholar
• Trepo C, Guillevin L. Polyarteritis nodosa and extrahepatic manifestations of HBV infection: The case against autoimmune intervention in pathogenesis. J Autoimmun 2001; 16: 269–274
   PubMed Web of Science ®Google Scholar
• Guillevin L, et al. Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges. Ann Rheum Dis 1994; 53: 334–337
   PubMedGoogle Scholar
• Ferri C, et al. B-cells and mixed cryoglobulinemia. Autoimmun Rev 2007; 7: 114–120
   PubMed Web of Science ®Google Scholar
• Agnello V. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection. Springer Semin Immunopathol 1997; 19: 111–129
   PubMedGoogle Scholar
• Ferri C, Bombardieri S. HCV and cryoglobulinemia. Infection and autoimmunity, Y Shoenfeld, NR Rose. Elsevier, Amsterdam/San Diego 2004; 201–212
   Google Scholar
• Ferri C, Mascia MT. Cryoglobulinemic vasculitis. Curr Opin Rheumatol 2006; 18: 54–63
   PubMed Web of Science ®Google Scholar
• Saadoun D, et al. Rituximab combined with Peg-Interferon-Ribavirin in refractory HCV-associated cryoglobulinemia vasculitis. Ann Rheum Dis, in press
   Google Scholar
• Genereau T, et al. Temporal arteritis symptoms in a patient with hepatitis C virus associated type II cryoglobulinemia and small vessel vasculitis. J Rheumatol 1998; 25: 183–185
   PubMedGoogle Scholar
• Ferraccioli GF, et al. Jaw and leg claudication in a patient with temporal arteritis, chronic sialoadenitis and previous hepatitis C virus infection. Clin Exp Rheumatol 1998; 16: 463–468
   PubMedGoogle Scholar
• Vassilopoulos D. Hepatitis C infection and vasculitis. Infection and autoimmunity, Y Shoenfeld, NR Rose. Elsevier, Amsterdam/San Diego 2004; 189–200
   Google Scholar
• Font C, et al. Polyarteritis nodosa in human immunodeficiency virus infection: Report of four cases and review of the literature. Br J Rheumatol 1996; 35: 796–799
   PubMedGoogle Scholar
• Pagnoux C, Cohen P, Guillevin L. Vasculitides secondary to infections. Clin Exp Rheumatol 2006; 24: S71–S81
   PubMed Web of Science ®Google Scholar
• Zandman-Goddard G, Shoenfeld Y. HIV and autoimmunity. Autoimmun Rev 2002; 1: 329–337
   PubMedGoogle Scholar
• Gherardi R, et al. Necrotizing vasculitis and HIV replication in peripheral nerves. N Engl J Med 1989; 321: 685–686
   PubMedGoogle Scholar
• Calabrese LH. The rheumatic manifestations of infection with the human immunodeficiency virus. Semin Arthritis Rheum 1989; 18: 225–239
   PubMed Web of Science ®Google Scholar
• Nieuwhof CM, Damoiseaux J, Cohen Tervaert JW. Successful treatment of cerebral vasculitis in an HIV-positive patient with anti-CD25 treatment. Ann Rheum Dis 2006; 65: 1677–1678
   PubMedGoogle Scholar
• Cioc AM, et al. Parvovirus B19 associated adult Henoch Schonlein purpura. J Cutan Pathol 2002; 29: 602–607
   PubMed Web of Science ®Google Scholar
• Corman LC, Dolson DJ. Polyarteritis nodosa and parvovirus B19 infection. Lancet 1992; 339: 491
   PubMed Web of Science ®Google Scholar
• Baskan EB, et al. Detection of parvovirus B19 DNA in the lesional skin of patients with Behcet's disease. Clin Exp Dermatol 2007; 32: 186–190
   PubMedGoogle Scholar
• Lehmann HW, von Landenberg P, Modrow S. Parvovirus B19 infection and autoimmune disease. Autoimmun Rev 2003; 2: 218–223
   PubMed Web of Science ®Google Scholar
• Helweg-Larsen J, et al. No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis. Rheumatology (Oxford) 2002; 41: 445–449
   PubMed Web of Science ®Google Scholar
• Eden A, et al. Lack of association between B19 or V9 erythrovirus infection and ANCA-positive vasculitides: A case-control study. Rheumatology (Oxford) 2003; 42: 660–664
   PubMedGoogle Scholar
• Finkel TH, et al. Chronic parvovirus B19 infection and systemic necrotising vasculitis: Opportunistic infection or aetiological agent?. Lancet 1994; 343: 1255–1258
   PubMed Web of Science ®Google Scholar
• Severin MC, Shoenfeld Y. Parvovirus B19 infection and its association to autoimmune disease. Infection and autoimmunity, Y Shoenfeld, NR Rose. Elsevier, Amsterdam/San Diego 2000; 181–188
   Google Scholar
• Martinelli C, et al. Cutaneous vasculitis due to human parvovirus B19 in an HIV-infected patient: Report of a case. Aids 1997; 11: 1891–1893
   PubMedGoogle Scholar
• Crowson AN, Magro CM, Dawood MR. A causal role for parvovirus B19 infection in adult dermatomyositis and other autoimmune syndromes. J Cutan Pathol 2000; 27: 505–515
   PubMed Web of Science ®Google Scholar
• Golden MP, et al. Cytomegalovirus vasculitis. Case reports and review of the literature. Medicine (Baltimore) 1994; 73: 246–255
   PubMedGoogle Scholar
• Meyer MF, et al. Cytomegalovirus infection in systemic necrotizing vasculitis: Causative agent or opportunistic infection?. Rheumatol Int 2000; 20: 35–38
   PubMedGoogle Scholar
• Taniwaki S, et al. Multiple ulcers of the ileum due to Cytomegalovirus infection in a patient who showed no evidence of an immunocompromised state. J Gastroenterol 1997; 32: 548–552
   PubMedGoogle Scholar
• Orloff JJ, et al. Toxic megacolon in cytomegalovirus colitis. Am J Gastroenterol 1989; 84: 794–797
   PubMedGoogle Scholar
• Koeppen AH, et al. Central nervous system vasculitis in cytomegalovirus infection. J Neurol Sci 1981; 51: 395–410
   PubMedGoogle Scholar
• Morgello S, et al. Cytomegalovirus encephalitis in patients with acquired immunodeficiency syndrome: An autopsy study of 30 cases and a review of the literature. Hum Pathol 1987; 18: 289–297
   PubMed Web of Science ®Google Scholar
• Magro CM, Crowson AN, Ferri C. Cytomegalovirus-associated cutaneous vasculopathy and scleroderma sans inclusion body change. Hum Pathol 2007; 38: 42–49
   PubMedGoogle Scholar
• Swanson S, Feldman PS. Cytomegalovirus infection initially diagnosed by skin biopsy. Am J Clin Pathol 1987; 87: 113–116
   PubMedGoogle Scholar
• Caruso JM, Tung GA, Brown WD. Central nervous system and renal vasculitis associated with primary varicella infection in a child. Pediatrics 2001; 107: E9
   PubMed Web of Science ®Google Scholar
• Kleinschmidt-DeMasters BK, Gilden DH. Varicella-Zoster virus infections of the nervous system: Clinical and pathologic correlates. Arch Pathol Lab Med 2001; 125: 770–780
   PubMed Web of Science ®Google Scholar
• Jain R, et al. Varicella-zoster vasculitis presenting with intracranial hemorrhages. AJNR Am J Neuroradiol 2003; 24: 971–974
   PubMed Web of Science ®Google Scholar
• Gilden DH, et al. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000; 342: 635–645
   PubMed Web of Science ®Google Scholar
• Kleinschmidt-DeMasters BK, Amlie-Lefond C, Gilden DH. The patterns of varicella zoster virus encephalitis. Hum Pathol 1996; 27: 927–938
   PubMed Web of Science ®Google Scholar
• Feigl D, Feigl A, Edwards JE. Mycotic aneurysms of the aortic root. A pathologic study of 20 cases. Chest 1986; 90: 553–557
   PubMedGoogle Scholar
• Miranda-Filloy JA, et al. Microscopic polyangiitis following recurrent Staphylococcus aureus bacteremia and infectious endocarditis. Clin Exp Rheumatol 2006; 24: 705–706
   PubMed Web of Science ®Google Scholar
• Fleischer B, Schrezenmeier H. T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells. J Exp Med 1988; 167: 1697–1707
   PubMed Web of Science ®Google Scholar
• Stegeman CA, et al. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med 1996; 335: 16–20
   PubMed Web of Science ®Google Scholar
• Yagi JJ, Rath S, Janeway CA, Jr. Control of T cell responses to staphylococcal enterotoxins by stimulator cell MHC class II polymorphism. J Immunol 1991; 147: 1398–1405
   PubMedGoogle Scholar
• Popa ER, Tervaert JW. The relation between Staphylococcus aureus and Wegener's granulomatosis: Current knowledge and future directions. Intern Med 2003; 42: 771–780
   PubMed Web of Science ®Google Scholar
• George J, et al. Infections and Wegener's granulomatosis—a cause and effect relationship?. QJM 1997; 90: 367–373
   PubMedGoogle Scholar
• Voswinkel J, et al. B lymphocyte maturation in Wegener's granulomatosis: A comparative analysis of VH genes from endonasal lesions. Ann Rheum Dis 2006; 65: 859–864
   PubMed Web of Science ®Google Scholar
• Brons RH, et al. Staphylococcal acid phosphatase binds to endothelial cells via charge interaction; a pathogenic role in Wegener's granulomatosis?. Clin Exp Immunol 2000; 119: 566–573
   PubMedGoogle Scholar
• Matsubara K, Fukaya T. The role of superantigens of group A Streptococcus and Staphylococcus aureus in Kawasaki disease. Curr Opin Infect Dis 2007; 20: 298–303
   PubMed Web of Science ®Google Scholar
• Tervaert JW, Popa ER, Bos NA. The role of superantigens in vasculitis. Curr Opin Rheumatol 1999; 11: 24–33
   PubMedGoogle Scholar
• Cimaz R, Falcini F. An update on Kawasaki disease. Autoimmun Rev 2003; 2: 258–263
   PubMed Web of Science ®Google Scholar
• Kao GF, et al. Cutaneous histopathology of Rocky Mountain spotted fever. J Cutan Pathol 1997; 24: 604–610
   PubMedGoogle Scholar
• Parola P, Paddock CD, Raoult D. Tick-borne rickettsioses around the world: Emerging diseases challenging old concepts. Clin Microbiol Rev 2005; 18: 719–756
   PubMed Web of Science ®Google Scholar
• Nadelman RB, Wormser GP. Lyme borreliosis. Lancet 1998; 352: 557–565
   PubMed Web of Science ®Google Scholar
• Mikkila HO, et al. The expanding clinical spectrum of ocular lyme borreliosis. Ophthalmology 2000; 107: 581–587
   PubMed Web of Science ®Google Scholar
• Halperin JJ, et al. Lyme neuroborreliosis: Central nervous system manifestations. Neurology 1989; 39: 753–759
   PubMed Web of Science ®Google Scholar
• Oksi J, et al. Inflammatory brain changes in Lyme borreliosis. A report on three patients and review of literature. Brain 1996; 119(Pt 6)2143–2154
   PubMedGoogle Scholar
• Komdeur R, et al. Immunosuppressive treatment for vasculitis associated with Lyme borreliosis. Ann Rheum Dis 2001; 60: 721
   PubMed Web of Science ®Google Scholar
• Pizzarello LD, et al. Temporal arteritis associated with Borrelia infection. A case report. J Clin Neuroophthalmol 1989; 9: 3–6
   PubMedGoogle Scholar
• Dourmishev LA, Dourmishev AL. Syphilis: Uncommon presentations in adults. Clin Dermatol 2005; 23: 555–564
   PubMed Web of Science ®Google Scholar
• Kennedy JL, Barnard JJ, Prahlow JA. Syphilitic coronary artery ostial stenosis resulting in acute myocardial infarction and death. Cardiology 2006; 105: 25–29
   PubMedGoogle Scholar
• Tavora F, Burke A. Review of isolated ascending aortitis: Differential diagnosis, including syphilitic, Takayasu's and giant cell aortitis. Pathology 2006; 38: 302–308
   PubMed Web of Science ®Google Scholar
• MacLeod CB, Johnson D, Frable WJ. “Tree-barking” of the ascending aorta. Syphilis or systemic lupus erythematosus?. Am J Clin Pathol 1992; 97: 58–62
   PubMedGoogle Scholar
• O'Regan AW, et al. Barking up the wrong tree? Use of polymerase chain reaction to diagnose syphilitic aortitis. Thorax 2002; 57: 917–918
   PubMed Web of Science ®Google Scholar
• Aldave AJ, King JA, Cunningham ET, Jr. Ocular syphilis. Curr Opin Ophthalmol 2001; 12: 433–441
   PubMed Web of Science ®Google Scholar
• Yokoi M, Kase M. Retinal vasculitis due to secondary syphilis. Jpn J Ophthalmol 2004; 48: 65–67
   PubMed Web of Science ®Google Scholar
• Chao YC, et al. A large ulcer and cutaneous small-vessel vasculitis associated with syphilis infection. Scand J Rheumatol 2006; 35: 147–151
   PubMed Web of Science ®Google Scholar